Putting GLP-1 drugs to the test Clinical trials on GLP-1 medications also follow these well-established patterns
Content: 55 ml
First, in a study of nearly 2k adults taking semaglutide, we observe a startling bodyweight uptick post-termination: Second, per reviews of major studies, some peoples weight loss is 40% muscle masswhich is a terrible outcome: Taken together, these side effects mean that, if you start and then stop, youve not only regained much of the weight, but youve lost muscle
SURMOUNT-MAINTAIN (Horn 2026, 112 weeks): continued top dose -21.9% vs 5 mg step-down -16.6% vs placebo -9.9%, rescue therapy 8/25/67%: Aronne JAMA 2024
Complementary proteomic approaches reveal mitochondrial dysfunction, immune and inflammatory dysregulation in a mouse model of Gulf War Illness
If you find that nausea is interfering with your daily life, it's time to talk to your healthcare provider